Ubhi Pharmacy Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—5

Registered number: 03222830

		2026		2025
	Notes	£	£	£	£
FIXED ASSETS
Tangible Assets	4		51,849		51,849
Investments	5		145,289		145,289

			197,138		197,138
CURRENT ASSETS
Debtors		92,702		51,547
Cash at bank and in hand		54,128		30,976

		146,830		82,523
Creditors: Amounts Falling Due Within One Year		(134,905 )		(192,833 )

NET CURRENT ASSETS (LIABILITIES)			11,925		(110,310 )

TOTAL ASSETS LESS CURRENT LIABILITIES			209,063		86,828

Creditors: Amounts Falling Due After More Than One Year			(32,255 )		(36,331 )

NET ASSETS			176,808		50,497

CAPITAL AND RESERVES
Called up share capital	6		40,000		40,000
Profit and Loss Account			136,808		10,497

SHAREHOLDERS' FUNDS			176,808		50,497

Page 1

Page 2

Ubhi Pharmacy Limited

Balance Sheet (continued)

As At 31 March 2026

For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Makhan Ubhi

Director

21/10/2026

The notes on pages 3 to 5 form part of these financial statements.

1. General Information

Ubhi Pharmacy Limited is a private company, limited by shares, incorporated in England & Wales, registered number 03222830 . The registered office is 71a Walsall Road, Litte Aston, Sutton Coldfield, West Midlands, B74 3BA.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Sale of goods

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

Rendering of services

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Tangible Fixed Assets and Depreciation

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Freehold

No depreciation

2.4. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

...CONTINUED

Page 3

Page 4

Ubhi Pharmacy Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2026

2.4. Taxation - continued

Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 5 (2025: 6)

4. Tangible Assets

	Land & Property
	Freehold
	£
Cost
As at 1 April 2025	51,849

As at 31 March 2026	51,849

Net Book Value
As at 31 March 2026	51,849

As at 1 April 2025	51,849

5. Investments

	Unlisted
	£
Cost or Valuation
As at 1 April 2025	145,289

As at 31 March 2026	145,289

...CONTINUED

Page 4

Page 5

Ubhi Pharmacy Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 March 2026

Provision
As at 1 April 2025	-

As at 31 March 2026	-

Net Book Value
As at 31 March 2026	145,289

As at 1 April 2025	145,289

6. Share Capital

	2026	2025
Allotted, called up and fully paid	£	£
27,000 Ordinary Shares of £ 1.00 each	27,000	27,000
2,500 Ordinary A shares of £ 1.00 each	2,500	2,500
2,500 Ordinary B shares of £ 1.00 each	2,500	2,500
2,000 Ordinary C shares of £ 1.00 each	2,000	2,000
4,000 Ordinary D shares of £ 1.00 each	4,000	4,000
2,000 Ordinary E shares of £ 1.00 each	2,000	2,000

	40,000	40,000

7. Related Party Transactions

As at 31 March 2026, the Company had the following outstanding balances with related parties within the group:

MAKS Chemist Limited: The Company had a receivable balance of £31,048 (2025: £31,048).

Mrs Amrit Pal Ubhi, Mr Karanjeet Singh Ubhi, Mr Makhan Singh Ubhi & Mr Sundeep Singh Ubhi were the directors of MAKS Chemist Limited as of 31 March 2026.

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Page 5